TL;DR
Researchers have engineered Streptomyces albus to produce more spinosad, a valuable insecticide, by fine-tuning the expression of key enzymes involved in its biosynthesis. By balancing the levels of two crucial enzymes, they significantly reduced the production of less active byproducts and boosted the yield of the desired spinosad by over five-fold. This work highlights the importance of stoichiometric control in metabolic engineering for optimizing natural product synthesis.
What Problem Does This Paper Address?
Spinosad is a potent and environmentally friendly insecticide derived from the bacterium Saccharopolyspora spinosa. However, its native producer is notoriously difficult to genetically manipulate, hindering efficient production. To overcome this, researchers previously engineered an artificial gene cluster for spinosad biosynthesis in a more amenable host, Streptomyces albus J1074, achieving a substantial increase in yield. Despite this improvement, a significant challenge remained: the co-production of N-monodesmethyl spinosad, a less active and undesired byproduct, at levels comparable to the desired spinosad. This byproduct not only reduces the overall yield of the active compound but also complicates purification. The paper aims to address this issue by investigating the underlying causes of N-monodesmethyl spinosad formation and developing strategies to eliminate it while further enhancing spinosad production.
Methods
The core of this study involves genetic engineering and fermentation optimization in Streptomyces albus J1074.
- Gene Cluster Engineering: The researchers utilized recombineering techniques to modify the existing artificial spinosad gene cluster. This involved inserting inducible and constitutive promoters upstream of key genes, specifically spnS (forosamine methyltransferase) and spnP (forosaminyl transferase).
- Inducible Expression: An inducible cymR-P21-cmt expression system was employed to control the expression of spnS. This system allows for precise tuning of gene expression by adding a chemical inducer (cumate) at varying concentrations.
- Constitutive Overexpression: Strong constitutive promoters (kasOp and SA15p) were used to achieve high-level, continuous expression of spnS and spnP*.
- Fermentation and Analysis: Engineered S. albus strains were cultured under controlled fermentation conditions. The resulting spinosad and its byproducts were extracted and analyzed using High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) to quantify their titers.
Datasets
Not discussed in the paper. The study relies on the engineered Streptomyces albus J1074 strains and their fermentation products as the "dataset" for analysis.
Key Insights and Ideas
- Unbalanced Expression is the Culprit: The paper strongly suggests that the accumulation of N-monodesmethyl spinosad is a direct consequence of unbalanced expression between the forosamine methyltransferase (spnS) and upstream biosynthetic genes. This imbalance leads to the accumulation of N-monodesmethyl forosamine, which is then inefficiently methylated.
- SpnS Expression Level Matters: Fine-tuning the expression of spnS is critical. Low levels of spnS expression lead to the formation of N-monodesmethyl spinosad, while higher levels reduce its production. However, simply overexpressing spnS alone only moderately increases spinosad yield.
- SpnP is a Bottleneck: Even with optimized spnS expression, the transfer of the fully methylated forosamine to the macrolide backbone by the forosaminyl transferase (spnP) can become a limiting step.
- Synergistic Effect of SpnS and SpnP Overexpression: The most significant improvement in spinosad production and reduction of byproducts was achieved by simultaneously overexpressing both spnS and spnP under strong constitutive promoters. This indicates a synergistic relationship between these two enzymes in driving efficient spinosad biosynthesis.
- Balanced Biosynthesis is Key: The study underscores a broader principle in metabolic engineering: achieving optimal production of complex natural products requires not just introducing the necessary genes but also carefully balancing their expression levels to prevent the buildup of unwanted intermediates.
Key Results
- Elimination of N-monodesmethyl spinosad: By tuning spnS expression, the content of N-monodesmethyl spinosad was reduced by over 90%.
- Moderate spinosad increase with spnS overexpression: Overexpressing spnS alone led to a less than 38% increase in spinosad titer.
- Significant spinosad yield improvement: Co-overexpressing spnS and spnP resulted in a 5.3-fold increase in spinosad titer, reaching 5.8 mg/L.
- Reduction of N,N-didesmethyl spinosad: The content of N,N-didesmethyl spinosad (spinosyn C) was also significantly decreased, becoming undetectable in optimized strains.
Limitations and Future Work
- Limitations:
- The paper notes that even with high spnS expression, the spinosad titer only increased by less than 38% when spnP was not also overexpressed. This highlights the limitation of optimizing only one enzyme in a pathway.
- The inducible promoter system used for spnS was described as "not completely tight," meaning there was some basal "leaky" expression even without the inducer, contributing to byproduct formation at low inducer concentrations.
- Future Work:
- The study implicitly suggests that further optimization of promoter strengths and the order of genes within the artificial cluster could lead to even higher yields and purity.
- The principle of balanced expression demonstrated here could be applied to the production of other complex natural products synthesized by multi-enzyme pathways, particularly those prone to byproduct formation.
- Exploring other tailoring enzymes in the spinosad pathway for further diversification or optimization could be a future direction.
Summary updated